EMEND Competitors

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 825* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,400 employees worldwide. *As of March 2026 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at PV@hikma.com

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. Together, PharmaLex and Cencora offer end-to-end product commercialization, including global market access strategy and execution, to drive patients’ healthier futures wherever they are in the world. PharmaLex complements Cencora’s existing suite of services by continuing to service the pharma, biotech and medtech industries, guiding clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.

Amoun established its third state-of-the-art factory (Amoun Pharmaceutical Co.) - designed by John Brown Co. in Chicago following all FDA requirements – and is today considered to be one of the largest and most modern pharmaceutical factories in the Middle East and Africa. Amoun has five branches in Egypt which between them, cover all major sales territories: Two branches in Cairo to cover, Amoun's the region of Greater Cairo, one branch in Mansoura to serve the Delta region, one branch in Alexandria to serve Alexandria, Behira, Kafr El-Sheikh and Matrouh Governorates, and one branch in Assuit to serve Upper Egypt, starting from Menia to Aswan Governorates. Since its establishment in 1985objective was, and still is, to supply the pharmaceutical market with high quality products. Amoun is considered to be one of the largest companies in the field of producing human and veterinary pharmaceutical products and food supplements; covering most of the pharmaceutical groups, including 144 items, which cover more than 264 products of different pharmaceutical forms and concentrations These pharmaceuticals take the form of capsules, tablets, dry syrups, powders, effervescents, syrups, solutions, drops, creams, suppositories, sprays, as well as sterile products such as ampoules, vials, sterile eye drops and eye ointments. Amoun’s veterinary products include 20 names covering 30 products of different forms and concentrations. Due to its prestigious reputation as a leading pharmaceutical manufacturer in Egypt, Amoun produces a number of products under licence from international pharmaceutical companies such as Merck (Germany), Rowa Wagner (Germany), Leurquin (France), and Guerbet (France) for diagnostic injectables. Our strategic plan aims to achieve the production of 110 million packages of different pharmaceutical forms amounting to approximately L.E. 780 million by 2009, and approximately 300 million packages amounting to (+/-) L.E. 2 billion by 2015.